ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 407 filers reported holding ENCOMPASS HEALTH CORP in Q1 2022. The put-call ratio across all filers is 0.39 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $281,419 | -0.8% | 4,190 | 0.0% | 0.14% | +2.2% |
| Q2 2023 | $283,690 | +25.2% | 4,190 | +0.0% | 0.14% | +16.0% |
| Q1 2023 | $226,639 | -25.2% | 4,189 | -37.4% | 0.12% | -43.9% |
| Q3 2022 | $303,000 | -19.2% | 6,688 | +0.0% | 0.21% | -17.8% |
| Q2 2022 | $375,000 | -21.1% | 6,687 | +0.0% | 0.26% | -8.8% |
| Q1 2022 | $475,000 | +8.9% | 6,686 | +0.0% | 0.28% | +11.9% |
| Q4 2021 | $436,000 | -13.1% | 6,685 | +0.0% | 0.25% | -18.1% |
| Q3 2021 | $502,000 | -3.8% | 6,684 | +0.0% | 0.31% | -9.1% |
| Q2 2021 | $522,000 | -4.6% | 6,683 | 0.0% | 0.34% | -10.3% |
| Q1 2021 | $547,000 | -1.1% | 6,683 | +0.0% | 0.38% | -9.8% |
| Q4 2020 | $553,000 | +27.4% | 6,682 | +0.0% | 0.42% | +19.3% |
| Q3 2020 | $434,000 | +4.8% | 6,681 | +0.0% | 0.35% | +1.4% |
| Q2 2020 | $414,000 | -3.3% | 6,680 | +0.0% | 0.35% | -11.3% |
| Q1 2020 | $428,000 | -7.6% | 6,679 | 0.0% | 0.39% | +17.1% |
| Q4 2019 | $463,000 | – | 6,679 | – | 0.33% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JANA PARTNERS LLC | 2,001,897 | $150,222,000 | 11.74% |
| JET CAPITAL INVESTORS L P | 855,100 | $64,167,000 | 10.95% |
| Davide Leone & Partners Investment Co Ltd. | 735,308 | $55,178,000 | 4.23% |
| Kent Lake Capital LLC | 110,000 | $8,254,000 | 3.55% |
| REINHART PARTNERS, LLC. | 604,274 | $53,309,000 | 2.71% |
| AREX Capital Management, LP | 74,000 | $5,553,000 | 2.59% |
| RK Capital | 179,800 | $13,492,000 | 2.55% |
| Orchard Capital Management, LLC | 108,266 | $8,124,000 | 2.44% |
| BARINGTON CAPITAL GROUP, L.P. | 24,200 | $1,816,000 | 1.88% |
| Sivik Global Healthcare LLC | 100,000 | $7,504,000 | 1.79% |